Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2000
02/10/2000WO2000006728A2 Phosphorylation effectors
02/10/2000WO2000006727A2 Human epidermal proteins hepi-1 to hepi-6
02/10/2000WO2000006725A1 Method for diagnosing hereditary diseases by using semaphorin w gene
02/10/2000WO2000006724A1 Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
02/10/2000WO2000006720A1 A novel regulatory molecule and genetic sequences encoding same
02/10/2000WO2000006714A1 DDKh-3 NUCLEIC ACIDS, POLYPEPTIDES, VECTORS, HOST CELLS, METHODS AND USES THEREOF
02/10/2000WO2000006709A1 Human protein kinase h2lau20
02/10/2000WO2000006699A1 Novel molecules of the tango-175-related protein family and uses thereof
02/10/2000WO2000006698A1 98 human secreted proteins
02/10/2000WO2000006696A2 Method for the modulation of function of transcription factors
02/10/2000WO2000006694A2 Compound and method for the prevention and/or the treatment of allergy
02/10/2000WO2000006605A2 Heterominibodies
02/10/2000WO2000006604A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases
02/10/2000WO2000006602A1 Cancer antigens based on tumor suppressor gene wt1 product
02/10/2000WO2000006601A1 Isoforms of human calcium sensing receptor
02/10/2000WO2000006599A1 Inhibitors of hiv membrane fusion
02/10/2000WO2000006596A2 Interferon alpha hybrids
02/10/2000WO2000006595A1 Hla-a2 restraint tumor antigen peptide originating in sart-1
02/10/2000WO2000006594A1 Novel thiazolidine derivatives
02/10/2000WO2000006589A1 Prostate derived ets factor
02/10/2000WO2000006534A1 Compounds and compositions for delivering active agents
02/10/2000WO2000006297A1 Compound storage
02/10/2000WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000WO2000006205A1 Regulated expression of recombinant proteins using rna viruses
02/10/2000WO2000006203A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis
02/10/2000WO2000006195A1 Targeting pharmaceutical agents to injured tissues
02/10/2000WO2000006193A1 Equine system for non-surgical artificial insemination
02/10/2000WO2000006192A1 Liver function ameliorating agents
02/10/2000WO2000006191A1 Method of treating polycystic ovarian syndrome using igf/igfbp-3
02/10/2000WO2000006190A1 THYMOSIN β4 PROMOTES WOUND REPAIR
02/10/2000WO2000006189A2 Conversion of naturally-occurring quinones to quinone derivatives by macrophage migration inhibition factor and uses thereof
02/10/2000WO2000006188A1 Hair growth/maintenance compositions and methods involving the same
02/10/2000WO2000006187A2 Modulation of apoptosis
02/10/2000WO2000006185A2 Methods of using lanreotide, a somatostatin analogue
02/10/2000WO2000006184A1 Pulmonary delivery of active agents
02/10/2000WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT
02/10/2000WO2000006179A1 Cryogranulation of activated protein c
02/10/2000WO2000006145A1 Methods for treating conditions modulated by lactosylceramide
02/10/2000WO2000006134A2 Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
02/10/2000WO2000006119A1 New injectable formulations containing ramoplanin
02/10/2000WO2000006108A1 Casein formulations for the delivery of bioactive constituents
02/10/2000WO2000006087A2 Uncoupling protein-2(hcp2): compositions and methods of use
02/10/2000WO2000006080A2 Agent for treating the clinical characteristics of crohn's disease
02/10/2000WO2000006032A1 Ultrasonic enhancement of drug injection
02/10/2000WO2000001729A3 Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome
02/10/2000WO2000000510A8 Growth factor modulators
02/10/2000WO1999065936A3 Composition for the treatement of immune deficiencies and methods for its preparation and use
02/10/2000WO1999064056A9 Use of a cytokine regulatory agent to treat asthma
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999062563A3 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
02/10/2000WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
02/10/2000WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
02/10/2000WO1999061044A9 Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
02/10/2000WO1999060024A9 Methods for amyloid removal using anti-amyloid antibodies
02/10/2000WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
02/10/2000WO1999058674A3 Method of inhibiting osteoclast activity
02/10/2000WO1999058557A3 Dimers of the hla-b27 heavy chain extracellular domain and uses thereof
02/10/2000WO1999058142A9 Use of anti-prolactin agents to treat proliferative conditions
02/10/2000WO1999058139A3 Methods for detecting and inhibiting angiogenesis
02/10/2000WO1999054479A9 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES
02/10/2000WO1999053038A3 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
02/10/2000WO1999049038A3 Human calcium-binding proteins
02/10/2000WO1999045126A3 Enhanced prodrug activation
02/10/2000WO1999045116A3 Human homolog of a nuclear migration gene and its use
02/10/2000WO1999042481A3 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF
02/10/2000WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins
02/10/2000WO1999024580A3 Essential fungal genes and their use
02/10/2000CA2340855A1 Granulocytic ehrlichia genes and uses thereof
02/10/2000CA2339301A1 Hdpbo81 nucleic acids and polypeptides
02/10/2000CA2339096A1 Modulation of apoptosis
02/10/2000CA2338928A1 Thymosin .beta.4 promotes wound repair
02/10/2000CA2338884A1 Liver function ameliorating agents
02/10/2000CA2338797A1 Hair growth/maintenance compositions and methods involving the same
02/10/2000CA2338779A1 Casein formulations for the delivery of bioactive constituents
02/10/2000CA2338766A1 Cryogranulation of activated protein c
02/10/2000CA2338699A1 Method of treating polycystic ovarian syndrome using igf/igfbp-3
02/10/2000CA2338396A1 Ultrasonic enhancement of drug injection
02/10/2000CA2338194A1 Equine system for non-surgical artificial insemination
02/10/2000CA2338022A1 Inhibitors of hiv membrane fusion
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2337743A1 Tumor antigen based on products of the tumor suppressor gene wt1
02/10/2000CA2337692A1 Kdel receptor inhibitors
02/10/2000CA2337496A1 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
02/10/2000CA2336549A1 Methods for treating conditions modulated by lactosylceramide
02/10/2000CA2336543A1 Isoforms of human calcium sensing receptor
02/10/2000CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000CA2336486A1 Hla-a2 restricted tumor antigen peptide originated from sart-1
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/10/2000CA2335654A1 Methods of using a somatostatin analogue
02/10/2000CA2335644A1 Phosphorylation effectors
02/10/2000CA2335643A1 C7f2-a novel potassium channel .beta.-subunit
02/10/2000CA2335228A1 Human epidermal proteins hepi-1 to hepi-6
02/10/2000CA2332526A1 New injectable formulations containing ramoplanin
02/10/2000CA2240611A1 Recombinant sendai virus vector expressing chemokine
02/09/2000EP0978562A1 Calcium/calmodulin dependent kinase and alternative splice product thereof
02/09/2000EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression
02/09/2000EP0978560A1 PROCESS FOR PRODUCING L-METHIONINE $g(g)-LYASE CRYSTALS
02/09/2000EP0978285A1 Pharmaceutical composition of hedgehog proteins and use thereof.
1 ... 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 ... 3163